FDA leaders have issued a statement regarding the agency’s plan moving forward with regards to authorizing COVID-19 vaccines for children.
In a news release attributed to acting commissioner Dr. Janet Woodcock and director of the FDA’s Center for Biologics Research and Evaluation Dr. Peter Marks, the FDA said it plans to “follow the science” with eyes on COVID-19 vaccines for children younger than 12 as schools begin to get back in session around the country.
Get the full story at our sister site, Drug Discovery & Development.